scholarly journals Association of Inventory to Measure and Assess imaGe Disturbance – Head and Neck Scores With Clinically Meaningful Body Image-Related Distress Among Head and Neck Cancer Survivors

2021 ◽  
Vol 12 ◽  
Author(s):  
David Macias ◽  
Brittany N. Hand ◽  
Patrik Pipkorn ◽  
Amy M. Williams ◽  
Steven S. Chang ◽  
...  

Objective: The Inventory to Measure and Assess imaGe disturbance – Head and Neck (IMAGE-HN) is a validated patient-reported outcome measure of head and neck cancer-related body image-related distress (BID). However, the IMAGE-HN score corresponding to clinically relevant BID is unknown. The study objective is to determine the IMAGE-HN cutoff score that identifies head and neck cancer patients with clinically relevant BID.Methods: We conducted a cross-sectional study at six academic medical centers. Individuals ≥18 years old with a history of head and neck cancer treated with definitive intent were included. The primary outcome measure was the IMAGE-HN. A Receiver Operating Characteristic curve analysis was performed to identify the IMAGE-HN score that maximized sensitivity and specificity relative to a Body Image Scale score of ≥10 (which indicates clinically relevant BID in a general oncology population). To confirm the validity of the IMAGE-HN cutoff score, we compared the severity of depressive [Patient Health Questionnaire-9 (PHQ-9)] and anxiety symptoms [Generalized Anxiety Disorder-7 (GAD-7)], and quality of life [University of Washington-QOL (UW-QOL)] in patients with IMAGE-HN scores above and below the cutoff.Results: Of the 250 patients, 70.4% were male and the mean age was 62.3 years. An IMAGE-HN score of ≥22 was the optimal cutoff score relative to a Body Image Scale score of ≥10 and represents a clinically relevant level of head and neck cancer-related BID. Relative to those with an IMAGE-HN score of <22, patients with IMAGE-HN scores of ≥22 had a clinically meaningful increase in symptoms of depression (mean PHQ-9 score difference = 5.8) and anxiety (mean GAD-7 score difference = 4.1) as well as worse physical (mean UW-QOL score difference = 18.9) and social-emotional QOL (mean UW-QOL score difference = 21.5). Using an IMAGE-HN cutoff score ≥22, 28% of patients had clinically relevant BID.Conclusion: An IMAGE-HN score of ≥22 identifies patients with clinically relevant head and neck cancer-related BID. This score may be used to detect patients who could benefit from strategies to manage their distress, select patients for studies evaluating interventions to manage head and neck cancer-related BID, and improve our understanding of the underlying epidemiology of the disorder.

2019 ◽  
Vol 161 (1) ◽  
pp. 105-110 ◽  
Author(s):  
Evan M. Graboyes ◽  
Elizabeth G. Hill ◽  
Courtney H. Marsh ◽  
Stacey Maurer ◽  
Terry A. Day ◽  
...  

This prospective cohort pilot study sought to characterize the short-term temporal trajectory of, and risk factors for, body image disturbance (BID) in patients with head and neck cancer (HNC). Most patients were male (35/56), had oral cavity cancer (33/56), and underwent microvascular reconstruction (37/56). Using the Body Image Scale (BIS), a validated patient-reported outcome measure of BID, the prevalence of BID (BIS ≥10) increased from 11% preoperatively to 25% at 1 month postoperatively and 27% at 3 months posttreatment ( P < .001 and P = .0014 relative to baseline, respectively). Risk factors for BID included female sex (odds ratio [OR], 4.8; 95% confidence interval [CI], 1.3-19.8), pT 3 to 4 tumors (OR, 8.9; 95% CI, 2.0-63.7), and more severe baseline shame and stigma (OR, 1.06; 95% CI, 1.01-1.13), depression (OR, 1.25; 95% CI, 1.06-1.51), and social isolation (OR, 1.21; 95% CI, 1.01-1.49). The prevalence and severity of BID increase immediately posttreatment. Demographic, oncologic, and psychosocial characteristics identify high-risk patients for targeted interventions.


2021 ◽  
Vol 6 (15) ◽  
pp. 57-64
Author(s):  
Emel Emine KAYIKÇI ◽  
Cemile SAVCI ◽  
Ayşe ÇİL AKINCI ◽  
Dilek YILDIRIM

Aims: The study was was conducted to determine the changes in sexual functions and the effect of gender and body image satisfaction on sexual function in patients with head and neck cancer who received radiotherapy or chemoradiotherapy after starting treatment. Methods: Forty three patients who underwent radiotherapy, radiotherapy (RT) or chemoradiotherapy (CRT) due to the diagnosis of head and neck cancer between October 2019 and March 2020 were included in the descriptive and correlational study. Research data were collected using the Structured Information Form, Arizona Sexual Experiences Scale and Body Image Satisfaction Scale at two different times, before and 6 weeks after the start of treatment. Results: Most of the patients participating in the study were male (55.8%) and married (74.4%). In the study, 69.8% of the patients had disease stages 1 and 2, and 65.1% of the patients had cancer in the pharynx and larynx. It was determined that 72.1% of the patients did not have a sexual problem before the diagnosis, and 90.7% of them had sexual problems after the diagnosis. There was a significant difference between the mean Arizona Sexual Experiences Scale scores of the patients before and after 6 weeks of RT/CRT (p<0.01); gender and Body Image Satisfaction Scale score significantly affected Arizona Sexual Experiences Scale score (R2=0.656, p<0.01). Conclusion: The treatment process in patients diagnosed with head and neck cancer undergoing RT/CRT causes sexual problems and worsening in sexual functions. Gender and body image satisfaction affect sexual function by 66%.


2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 6050-6050 ◽  
Author(s):  
Leanne Kolnick Jackson ◽  
Jie Deng ◽  
Sheila H. Ridner ◽  
Mary S. Dietrich ◽  
Barbara A. Murphy

2020 ◽  
Vol 162 (3) ◽  
pp. 304-312 ◽  
Author(s):  
Evan M. Graboyes ◽  
Elizabeth G. Hill ◽  
Courtney H. Marsh ◽  
Stacey Maurer ◽  
Terry A. Day ◽  
...  

Objectives To characterize the temporal trajectory of body image disturbance (BID) in patients with surgically treated head and neck cancer (HNC). Study Design Prospective cohort study. Setting Academic medical center. Subjects and Methods: Patients with HNC who were undergoing surgery completed the Body Image Scale (BIS), a validated patient-reported outcome measure of BID, pretreatment and 1, 3, 6, 9, and 12 months posttreatment. Changes in BIS scores (ΔBIS) relative to pretreatment (primary endpoint) were analyzed with a linear mixed model. Associations between demographics, clinical characteristics, psychosocial attributes, and persistently elevated BIS scores and increases in BIS scores ≥5 points relative to pretreatment (secondary endpoints) were analyzed through logistic regression. Results Of the 68 patients, most were male (n = 43), had oral cavity cancer (n = 37), and underwent microvascular reconstruction (n = 45). Relative to baseline, mean ΔBIS scores were elevated at 1 month postoperatively (2.9; 95% CI, 1.3-4.4) and 3 (3.2; 95% CI, 1.5-4.9) and 6 (1.8; 95% CI, 0.02-3.6) months posttreatment before returning to baseline at 9 months posttreatment (0.9; 95% CI, –0.8 to 2.5). Forty-three percent of patients (19 of 44) had persistently elevated BIS scores at 9 months posttreatment relative to baseline, and 51% (31 of 61) experienced an increase in BIS scores ≥5 relative to baseline. Conclusions In this cohort of patients surgically treated for HNC, BID worsens posttreatment before returning to pretreatment (baseline) levels at 9 months posttreatment. However, 4 in 10 patients will experience a protracted course with persistent posttreatment body image concerns, and half will experience a significant increase in BIS scores relative to pretreatment levels.


Sign in / Sign up

Export Citation Format

Share Document